Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,415.50 +80.21 0.52%
S&P 500 1,673.81 +7.52 0.45%
Nasdaq 3,505.17 +8.74 0.25%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

POZN:US

4.9700 USD 0.0100 0.20%

As of 14:21:37 ET on 05/21/2013.

Company Profile for Pozen Inc (POZN)

POZEN Inc. is a pharmaceutical company that develops therapeutics for diseases with unmet medical needs. The Company's product candidates include migraine treatments as well as is exploring the development of product candidates in other pain-related therapeutic areas.

Contact Information

Pozen Inc

1414 Raleigh Road
Suite 400
Chapel Hill, NC 27517
United States
Phone: 1-919-913-1030
Fax: 1-919-913-1039

Key Executives for Pozen Inc (POZN)

John R PlachetkaChairman/President/CEOJohn G FortChief Medical Officer
Elizabeth A Cermak "Liz"Exec VP/Chief Commercial OfcrTomas S BocanegraExec VP:Product Development
Gilda M ThomasSenior VP/Secy/Gen CnslWilliam L HodgesSenior VP:Finance & Admin/CFO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil